HSP27 expression in neuroblastoma: Correlation with disease stage

Journal of the National Cancer Institute

Volumn 86, Issue 10, 1994, Pages 780-784

  Ungar, David R ^a   Hailat, Nabil ^d   Strahler, John R ^a   Kuick, Rork D ^a   Brodeur, Garrett M ^b   Seeger, Robert C ^c   Reynolds, C Patrick ^c   Hanash, Samir M ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d JORDAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Jordan)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN; HEAT SHOCK PROTEIN 27; RETINOIC ACID;

ARTICLE; CANCER STAGING; GENE AMPLIFICATION; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NERVE CELL DIFFERENTIATION; NEUROBLASTOMA; ONCOGENE C MYB; POLYACRYLAMIDE GEL ELECTROPHORESIS;

ELECTROPHORESIS, POLYACRYLAMIDE GEL; GENE EXPRESSION; GENES, MYC; HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM STAGING; NEUROBLASTOMA; TUMOR CELLS, CULTURED;

EID: 0028359937     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/86.10.780     Document Type: Article

References (40)

1. Young JL Jr., Ries LC, Silverberg E, et al: Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer 58,598-602,1986.
2. Bernstein ML, Leclerc JM, Bunin G, et al: A population-based study of neuroblastoma incidence, survival, and mortality in North America. J Clin Oncol 10:323-329, 1992.
3. Breslow N, McCann B: Statistical estimation of prognosis for children with neuroblastoma. Cancer Res 31:2098-2103, 1971.
4. Seeger RC, Brodeur GM, Sather H, et al: Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N Engl J Med 313:1111-1116, 1985.
5. Look AT, Hayes FA, Shuster JJ, et al: Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol 9:581-591, 1991.
6. Cohn SL, Rademaker AW, Salwen HR, et al: Analysis of DNA ploidy and proliferative activity in relation to histology and N-myc amplification in neuroblastoma. Am J Pathol 136:1043-1052,1990.
7. Fong C-T, Dracopoli NC, White PS, et al: Loss of heterozygosity for the short arm of chromosome I in human neuroblastomas: correlation with N-myc amplification. Proc Natl Acad Soi U S A 86:3753-3757, 1989.
8. Fong C-T, White PS, Petersen K, et al: Loss of heterozygosity for chromosome 1 or 14 defines subsets of advanced neuroblastoma. Cancer Res 52:1780-1785, 1992.
9. Shimada H, Chatten J, Newton WA Jr., et al: Histopathologic prognostic factors in neuro-blastic tumors: definition of subtypes of gangliorteuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73:405-416, 1984.
10. Evans AE, D'Angio GJ, Randolph J: A proposed staging system for children with neuroblastoma. Children’s cancer study group A. Cancer 27:374-378, 1971.
11. Nickerson HJ, Nesbitt ME, Grosfeld JL, et al: Comparison of stage [V and IV-S neuroblastoma in the first year of life. Med Pediatr Oncol 13:261-268, 1985.
12. Arrigo A-P, Welch WJ: Characterization and purification of the small 28,000-dalton mammalian heat shock protein. J Biol Chem 262:15359-15369, 1987.
13. Landry J, Lambert H, Zhou M, et al: Human HSP27 is phosphorylated at serines 78 and 82 by heat shock and mitogen-activated kinases that recognize the same amino acid motif as S6 kinase II. J Biol Chem 267:794-803, 1992.
14. Slrahler JR, Kuick R, Eckerskom C, et al: Identification of two related markers for common acute lymphoblastic leukemia as heat shock proteins. J Clin Invest 85:200-207, 1990.
15. Seymour L, Bezwoda WR, Meyer K. et al: Detection of p24 protein in human breast cancer: influence of receptor status and oestrogen exposure. Br J Cancer 61:886-890, 1990.
16. Seymour L, Bezwoda WR, Meyer K: Tumor factors predicting for prognosis in metastatic breast cancer. The presence of p24 predicts for response to treatment and duration of survival. Cancer 66:2390-2394, 1990.
17. Thor A, Benz C, Moore D II, et al: Stress response protein (srp-27) determination in primary human breast carcinomas: clinical, histologic, prognostic correlations. J Natl Cancer Inst 83:170-178, 1991.
18. Tern B. Lacasse B. Bouchard H-L, et al: Prognostic influence of HSP-27 expression in malignant fibrous histiocytoma: a clinicopath-ological and immunohistochemical study. Cancer Res 52:2325-2328, 1992.
19. Brodeur GM, Seeger RC, Schwab M, et al: Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 224:1121-1124, 1984.
20. Merril CR, Goldman D, Sedman SA, et al: Ultrasensitive stain for proteins in polyacrylamide gels show regional variation in cerebrospinal fluid proteins. Science 211:1437-1438, 1981.
21. Kuick R, Hanash SM, Chu EY, et al: A comparison of some adjustment techniques for use with quantitative spot data from two-dimensional gels. Electrophoresis 8:199-207, 1987.
22. Bitar KN, Kaminski MS, Hailat N, et al: HSP27 is a mediator of sustained smooth muscle contraction in response to bombesin. Biochem Biophys Res Commun 181:1192-1200,1991.
23. Reynolds CP, Tomayko MM, Donner L, et al: Biological classification of cell lines derived from human extra-cranial neural tumors. Prog Clin Biol Res 271.291-306. 1988.
24. Ang D, Liberek K, Skowyra D. et al: Biological role and regulation of the universally conserved heat shock proteins. J Biol Chem 266:24233-24236,1991.
25. Kochevar DT, Aucoin MM, Cooper J: Mammalian heat shock proteins: an overview with a systems perspective. Toxicol Lett 56:243-267, 1991.
26. Schlesinger MJ: Heat shock proteins. J Biol Chem 265:12111-12114, 1990.
27. Ciocca DR, Fuqua SAW, Lock-Lim S, et al: Response of human breast cancer cells to heat shock and chemotherapeutic drugs. Cancer Res 52:3648-3654, 1992.
28. Huot J, Roy G, Lambert H, et al: Increased survival after treatments with anticancer agents of Chinese hamster cells expressing the human Mr 27,000 heat shock protein. Cancer Res 51:5245-5252, 1991.
29. Jacewicz M, Kiessling M, Pulsinelli WA: Selective gene expression in focal cerebral ischemia. J Cereb Blood Flow Metab 6:263-272, 1986.
30. Pauli D, Tonka C-H, Tissieres A, et al: Tissue-specific expression of the heat shock protein HSP27 during Drosophila melanogaster development. J Cell Biol 111:817-828, 1990.
31. Cooper MJ, Hutchins GM, Cohen PS, et al: Human neuroblastoma tumor cell lines correspond to the arrested differentiation of chromaffin adrenal medullary neuroblasts. Cell Growth Diff 1:149-159, 1990.
32. Tonini GP, Parodi MT, Di Martino D, et al: Expression of protein kinase C-alpha (PKC-alpha) and MYCN mRNAs in human neuroblastoma cells and modulation during morphological differentiation induced by retinoic acid. FEBS Lett 280:221-224, 1991.
33. Bernards R: N-myc disrupts protein kinase C-mediated signal transduction in neuroblastoma. EM BO J 10:1119-1125, 1991.
34. Hailat N, Strahler J, Melhem R, et al: N-myc gene amplification in neuroblastoma is associated with altered phosphorylation of a proliferation related polypeptide (Op 18). Oncogene 5:1615-1618, 1990.
35. Hailat N, Keim DR, Melhem RF, et al: High levels of P19/nm23 protein in neuroblastoma are associated with advanced stage disease and with N-myc gene amplification. J Clin Invest 88:341-345,1991.
36. Tanaka T, Slamon DJ, Shimada H, et al: A significant association of Ha-ras p21 in neuroblastoma cells with patient prognosis. Cancer 68:1296-1302, 1991.
37. Thiele CJ, Reynolds CP, Israel MA: Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma. Nature 313:404-406, 1985.
38. Pechan PM: Heat shock proteins and cell proliferation. FEBS Lett 280:1-4, 1991.
39. Spector NL, Samson W, Ryan C, et al: Growth arrest of human B lymphocytes is accompanied by induction of the low molecular weight mammalian heat shock protein (Hsp28). J Immunol 148:1668-1673, 1992.
40. Zantema A, De Jong E, Lardenoije R, et al: The expression of heat shock protein hsp27 and a complexed 22-kilodalton protein is inversely correlated with oncogenicity of adenovirus-transformed cells. J Virol 6:3368-3375,1989.